As of 2026-04-03, the EV/EBITDA ratio of Sinsin Pharmaceutical Co Ltd (002800.KQ) is 9.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 002800.KQ's latest enterprise value is 127,310.30 mil KRW. 002800.KQ's TTM EBITDA according to its financial statements is 12,993.26 mil KRW. Dividing these 2 quantities gives us the above 002800.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 7.2x | 5.9x |
| Forward P/E multiples | 4.4x - 6.4x | 5.5x |
| Fair Price | 715.80 - 3,378.91 | 1,895.82 |
| Upside | -87.1% - -39.3% | -66.0% |
| Date | EV/EBITDA |
| 2026-03-24 | 9.74 |
| 2026-03-23 | 9.63 |
| 2026-03-20 | 9.86 |
| 2026-03-19 | 9.75 |
| 2026-03-18 | 9.83 |
| 2026-03-17 | 9.83 |
| 2026-03-16 | 9.80 |
| 2026-03-13 | 9.94 |
| 2026-03-12 | 9.83 |
| 2026-03-11 | 9.80 |
| 2026-03-10 | 9.70 |
| 2026-03-09 | 9.63 |
| 2026-03-06 | 9.93 |
| 2026-03-05 | 9.89 |
| 2026-03-04 | 9.35 |
| 2026-03-03 | 9.93 |
| 2026-02-27 | 10.11 |
| 2026-02-26 | 10.25 |
| 2026-02-25 | 10.48 |
| 2026-02-24 | 10.60 |
| 2026-02-23 | 10.63 |
| 2026-02-20 | 10.52 |
| 2026-02-19 | 10.48 |
| 2026-02-13 | 10.22 |
| 2026-02-12 | 10.34 |
| 2026-02-11 | 10.22 |
| 2026-02-10 | 10.16 |
| 2026-02-09 | 10.04 |
| 2026-02-06 | 10.03 |
| 2026-02-05 | 10.04 |
| 2026-02-04 | 10.13 |
| 2026-02-03 | 10.00 |
| 2026-02-02 | 9.86 |
| 2026-01-30 | 9.94 |
| 2026-01-29 | 10.08 |
| 2026-01-28 | 10.00 |
| 2026-01-27 | 10.10 |
| 2026-01-26 | 10.13 |
| 2026-01-23 | 10.02 |
| 2026-01-22 | 9.98 |
| 2026-01-21 | 9.91 |
| 2026-01-20 | 10.09 |
| 2026-01-19 | 10.04 |
| 2026-01-16 | 10.03 |
| 2026-01-15 | 10.06 |
| 2026-01-14 | 9.84 |
| 2026-01-13 | 9.94 |
| 2026-01-12 | 10.14 |
| 2026-01-09 | 10.09 |
| 2026-01-08 | 10.08 |